This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cardiac Ambulatory Monitoring Market

Market Insights on Cardiac Ambulatory Monitoring covering sales outlook, demand forecast & up-to-date key trends

Cardiac Ambulatory Monitoring Market by Product, End User & Region - Forecast 2022 - 2032

Cardiac Ambulatory Monitoring Market Snapshot

[250 Pages Report] The global cardiac ambulatory monitoring market enjoys a valuation of US$ 13.3 Bn in 2021, and it is further projected to expand at a CAGR of 5.2% over the forecast years. According to a recent study by Future Market Insights, ECG devices are leading the cardiac ambulatory monitoring market with a share of about 42.2 % in the year 2021.

Market Outlook:

Data Points

Market Insight

Market Value 2021

US$ 13.3 Bn

Estimated market Value 2022

US$ 13.9 Bn

Estimated market Value 2032

US$ 21.6 Bn

CAGR of 2022-2032

4.5 %

Market share of Top 5 countries

61.3 %

Key Market players

Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, iRhythm Technologies Inc, Biotronik, Schiller, Medicomp Inc., Koninklijke Philips N.V., Applied Cardiac System, and MicroPort

Ambulatory cardiac monitors are electrocardiograph devices that can record the heart's rhythm. The characteristics of these monitors vary depending on how long they can record and whether they can deliver recordings over the phone.

The majority of qualified professionals utilize ambulatory cardiac monitors to check heartbeat rate over time, correlate symptoms with the heartbeat, identify irregular heart rhythms, and examine additional symptoms a heart may present. With longer detection times and more accurate data, these devices provide assistance in heart monitoring.

Cardiac ambulatory monitoring devices help doctors identify irregular cardiac rhythms that occur occasionally and unexpectedly.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analyses of Cardiac Ambulatory Monitoring Market 2015-2021 Vs Market Outlook for 2022-2032

Between 2015 and 2021, the cardiac ambulatory monitoring market grew at a CAGR of 5.2%.

The global market for cardiac ambulatory monitoring held around 59.1% share within the global cardiac monitoring devices market, worth around US$ 22.5 Bn, in 2021.

Some of the most important CVD (cardiovascular disease) risk factors are family history, ethnicity, and age. Diabetes, inactivity, tobacco use, a poor diet, high cholesterol, obesity, high blood pressure (hypertension), and alcohol consumption are all risk factors. The prevalence of diseases like hypertension, diabetes, dyslipidemia, and obesity has increased due to changes in lifestyle, which also contributes to the global rise in the risk of CVD.

In the European Union, more than 60 million people have cardiovascular disease, and about 13 million new cases are diagnosed each year, according to statistics published by the European Society of Cardiology in June 2020. The market for cardiac ambulatory monitoring is anticipated to expand as a result of the rising prevalence of cardiovascular illnesses and the consequent rise in the demand for patient monitoring systems.

As per the data provided by WHO, cardiovascular diseases are the most common cause of death worldwide, claiming an average of 17.9 million lives yearly. Furthermore, according to the same data from the WHO, stroke and heart attacks account for the majority of deaths than other cardiovascular disease deaths, and the majority of these deaths are reported to happen before the age of 70. The majority of CVD deaths occur in growing economies.

The development of the market is anticipated to be fuelled by advanced product launches and strategic initiatives by major market competitors. For instance, in June 2021, AliveCor purchased CardioLabs, an industry-leading provider of monitoring and cardiac diagnostic services, from an independent diagnostic testing facility (IDTF). The acquisition was a key component of AliveCor's objective to offer a full range of cardiac diagnostic services to patients for whom their doctors have prescribed monitoring devices.

Thus, the above-mentioned factors are expected to act as possible market drivers to propel the global cardiac ambulatory monitoring market during the forecast period.

Cardiac Ambulatory Monitoring Market Download Report Brochure

What are the Opportunities for the Manufacturers Operating within the Global Cardiac Ambulatory Monitoring Market to Expand In The Future?

One of the main drivers of the growth of the cardiac ambulatory monitoring market is the usage of the most cutting-edge and minimally invasive surgical techniques to enhance patients' heart activity and amplify the results of various cardiac surgeries.

Furthermore, the market for cardiac ambulatory monitoring is predicted to grow as demand for advanced cardiac devices such as implantable loop recorders, event monitors, mobile cardiac telemetry, and Holter monitors grows. Additionally, favorable reimbursement practices, rising public and private healthcare spending, and other key aspects are driving the cardiac ambulatory monitoring market.

Cardiovascular monitoring devices have significantly improved as a result of recent advancements in heart monitoring equipment, particularly mobile cardiac telemetry (MCT) systems.

Moreover, to enhance CIED (cardiac implantable electronic devices) stability in the subcutaneous pocket and elute the antibiotics minocycline and rifampin, Medtronic offers an absorbable, multifilament mesh envelope (TYRX Absorbable Antibacterial Envelope).

Implantable cardioverter defibrillators (ICDs) and pacemakers are only a couple of examples of CIEDs that can be used with these envelopes. The envelope reduced the incidence of infection by 40% when compared to regular infection prevention alone.

The abovementioned factors are capable of serving as some lucrative opportunities for manufacturers operating in the cardiac ambulatory monitoring market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Probable Factors Restraining the Demand within the Cardiac Ambulatory Monitoring Market?

When used to treat cardiac arrhythmias, CIEDs are linked to improved quality of life and survival rates. However, a significant risk factor for using these devices is CIED-associated infections. Patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators are most likely to get CIED infections. The rate of CIED infections was 1.19% for pacemakers, 1.91% for implantable cardioverter-defibrillators, 2.18% for cardiac resynchronization therapy pacemakers (CRT-Ps), and 3.35% for CRT defibrillators, according to the European Heart Journal (CRTDs).

Medical device cybersecurity issues, particularly those in CIEDs that could be reprogrammed or rendered useless, are a major source of concern for both patients and healthcare professionals.

Mobile phones and mp3 players, metal detectors, magnets, high-voltage electrical wires, and electrical devices like toothbrushes, shavers, and microwaves can also hamper signals if the monitoring devices are in close proximity.

Self-care Management and Long-term ECG Monitoring Drive U.S. Cardiac Ambulatory Monitoring Market Growth

  • By 2021, the U.S. market for ambulatory cardiac monitoring devices would be worth US$ 4.6 Billion
  • The cardiac ambulatory monitoring market in the US is projected to grow at a CAGR of 7.4% from 2022 to 2032.
  • Approximately US$ 9.0 Bn is expected to be generated by the ambulatory cardiac monitoring devices market by the end of 2032 in the U.S.

A growing number of cardiovascular surgeries has led to the use of ambulatory cardiac monitoring devices to continuously monitor cardiovascular patients in the US. Ambulatory cardiac monitoring devices are currently required to track and monitor the heart to prevent fatal outcomes from cardiovascular diseases. Approximately 40,000 children in the U.S. undergo congenital heart surgery each year, according to an article published in October 2020 titled, "National Variation in Congenital Heart Surgery Outcomes."

ECG devices record heartbeats using electrical impulses, amplified and displayed on an ECG display. They are used to diagnose heart diseases and arrhythmias in a person and to help determine the most appropriate treatment. Electrocardiograms can be obtained at home with a portable ECG device, thanks to advances in technology. More than 60% of the global population suffers from cardiovascular diseases, according to the World Health Organization.

The ambulatory cardiac monitoring devices market in the U.S. is consolidated, with the presence of a small number of leading players. Several companies are investing heavily in research and development activities, mainly to introduce advanced ambulatory cardiac monitoring devices to the market. To increase revenue and market share, key players form strategic alliances. They also diversify their product portfolios and acquire other companies.

There are several prominent players operating in the U.S. ambulatory cardiac monitoring devices market, including Abbott Laboratories, Biotronik, Boston Scientific Corporation, Hill-Rom Holdings, GE Healthcare, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation.

The Portrait Mobile wireless patient monitoring system, announced by GE Healthcare in June 2022, provides continuous monitoring throughout a patient's stay. The system helps clinicians detect the deterioration of the patient. In addition to reducing the length of stay and ICU admissions, early detection of patient deterioration may improve patient outcomes.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Increased Prevalence of Obesity across all Age Groups in Europe Spurs Demand for Cardiac Ambulatory Monitoring

Germany dominates the European cardiac ambulatory monitoring market by achieving a valuation of US$ 0.79 Bn. This is despite retaining a market share of about 5.6% in the global market, in 2022. Europe is one of the largest markets for cardiac ambulatory monitoring across the globe. As the population ages, cardiac issues are on the rise.

Additionally, wearable devices for ambulatory cardiac monitors that incorporate advanced software, analytical tools, and artificial intelligence have been introduced to satisfy the increasing demand for holistic, multi-input, and patient-driven devices for complex physiology. As an example, Cambridge Heartware, a UK-based healthcare company, has introduced a wearable heart monitor that sends recorded data to the cloud so adaptive artificial intelligence algorithms can diagnose irregular heart rates that are clinically relevant.

Moreover, minimally invasive diagnostic tools and preventative healthcare devices are driving the market. In addition, governments in the region are creating awareness of cardiovascular disorders, which is driving the market forward.

Due to a large number of large, medium, and small players, the European cardiac monitoring market is extremely fragmented and specialized. To improve their market position, multinational players hold a substantial share of the cardiac monitoring market. To enhance their market presence, companies are focusing on several growth strategies, including mergers and acquisitions, partnerships, collaborations, and geographical expansions.

Japan Cardiac Ambulatory Monitoring Market is Fuelled by the Adoption of Minimally Invasive Procedures

According to the forecast, Japan’s cardiac ambulatory monitoring market may grow at a CAGR of 3.1% in the forecasted period. The increasing cardiovascular disease burden and the increased adoption of minimally invasive procedures are driving the market growth in Japan's cardiac ambulatory monitoring market.

In December 2021, the National Cerebral and Cardiovascular Center, Japan, estimated that approximately 1.2 million Japanese people would suffer from heart failure by 2020. Additionally, based on the same source, heart failure patients are expected to increase in Japan, where people live to be 100 years old. This is because cardiovascular disease prevalence increases with age. Heart failure is one of the most prevalent conditions in Japan, which is expected to drive the adoption of cardiovascular devices.

Japan is also one of the nations with the fastest-aging population in the world. According to World Data 2022, there were 28% of people aged 65 and above in 2020 and 29% in 2021. The increase in the geriatric population in Japan is expected to drive market growth because geriatric people are more likely to suffer from chronic diseases like cardiovascular diseases.

Increased initiatives from key players in the market are also expected to drive market growth in Japan due to the rise in sales of cardiac ambulatory monitoring products. A distribution agreement between Rampart IC and Japan Lifeline (JLL) was signed in March 2022, securing distribution in the Japanese market. In addition to being designed for interventional cardiologists, the Rampart M1128 has been applied to a variety of interventional specialties.

As a result of these distribution partnerships, cardiovascular devices may be adopted more widely, driving the market growth. For instance, As of January 2022, Medtronic's Micra AV Transcatheter Pacing System (TPS) has been approved and reimbursed by Japan's Ministry of Health, Labor, and Welfare. The company is preparing to launch the device.

Changing Lifestyles Result in a Higher Burden of Chronic Diseases in Korea, which Drives the Market

The increasing prevalence of chronic diseases such as cardiovascular diseases among the population is expected to increase the demand for cardiac ambulatory monitoring devices, thereby propelling the cardiac ambulatory monitoring market growth in Korea. In addition, the growing geriatric population is also contributing to the market's growth.

According to the United Nations Population Fund's 2022 statistics, in Korea, 71% of the population is aged 15-64, which constitutes a large proportion of the living population. Additionally, according to the same source, 17% of the population will be 65 years or older by 2022. Thus, chronic disease is more likely to develop in the geriatric population.

Furthermore, the rising product launches and company activities in Korea are also expected to boost the cardiac ambulatory monitoring market over the forecast period. A South Korean healthcare start-up, Sky Labs, launched a wearable, ring-type heart rhythm monitoring device in November 2021 that detects atrial fibrillation (AF) and prevents heart-related problems. Additionally, Samsung launched in Korea a Health Monitoring Application, which can monitor blood pressure and ECGs.

Country Wise Insights

How is the U.S. Dominating the North American Cardiac Ambulatory Monitoring Market?

As of 2021, the U.S. held the greatest share of the global market at about 34.6% and generated revenue of around US$ 4.6 Bn. The country is anticipated to experience significant expansion as a result of positive government efforts, increased technological advancements, rising cardiovascular disease prevalence, and rapid economic growth. For instance, the geriatric population in the U.S. is 16.8% of the total population, according to details published by the Organization for Economic Co-operation and Development in 2021. The market is expected to expand as a result of the rise in demand for cardiac pacemakers brought on by the aging population due to increasing incidences of cardiovascular issues.

Which Country drives the European Cardiac Ambulatory Monitoring Market?

In the European region, Germany dominates the cardiac ambulatory monitoring market by achieving a valuation of US$ 0.75 Bn withholding the market share of about 5.6% in the global market, in 2021. According to data published by the European Society of Cardiology in June 2020, more than 60 million people in the European Union have cardiovascular disease, and about 13 million new cases are diagnosed each year. The cardiac ambulatory monitoring market is anticipated to expand as a result of the rising incidence of cardiovascular disorders and the consequent rise in the requirement for cardiac ambulatory monitoring devices.

How is China Dominating the East Asian Cardiac Ambulatory Monitoring Market?

At the end of 2021, China held a market share of about 9.2% in the global cardiac ambulatory monitoring market. Cardiac ambulatory monitoring device adoption is particularly high in China. According to a study that was published in the Radcliffe Cardiology journal, heart failure is a serious health concern in China, where it appears to be more common than in Western nations. The market in the region is being driven by an increase in awareness of heart failure and the danger of sudden cardiac arrest associated with this disease.

Category Wise Insights

Which Product is driving the Global Cardiac Ambulatory Monitoring Market?

In 2021, the ECG category contributed about 42.2% share in the global market in 2021. This is explained by the fact that, as compared to other short- and long-term monitoring equipment, these devices provide a quicker and more accurate diagnosis of cardiac health. Additionally, compared to other devices, ECG devices have relatively lower pricing. These devices can also be utilised in medical operations, along with a variety of other cardiac diagnostic tests, telemetry monitoring equipment, and other tools.

Which End-User Segment Leads the Global Cardiac Ambulatory Monitoring Market?

Hospitals hold about US$ 4.7 Bn in revenue with 35.0% of the majority of the global market share in 2021. The rising incidence of CVDs, the rising number of hospital visits, the rising number of cardiac device implantation procedures, and the availability of reimbursement for these procedures, propel the expansion of this segment.

According to CDC (centers for disease control and prevention) report, in the U.S., hospitals see about 6.9% of patients with ischemic heart disease, coronary artery disease, or a history of myocardial infarction each year, whereas emergency rooms see about 7.2% of patients with heart diseases.

Competitive Landscape

The existence of numerous industry rivals has led to a slight fragmentation and concentration of the cardiac ambulatory monitoring market. Cardiac ambulatory monitoring devices offer a new paradigm in healthcare by gathering and analysing long-term data for accurate diagnosis. These devices are becoming increasingly used for monitoring chronic heart disease.

The key manufacturers' strategic initiatives and the introduction of advanced products are anticipated to fuel the industry's expansion throughout the forecast period.

For Instance:

  • In July 2021, The LINQ II insertable cardiac monitor can now use two Medtronic AI algorithms that have been authorised by the FDA. The LINQ II-captured cardiac rhythm event data is improved in precision and accuracy by the AccuRhythm AI algorithms.
  • AliveCor Inc. launched the KardiaMobile Card, a small and convenient personal ECG device, in February 2022. It takes 30 seconds to perform a single-lead ECG and is the size of a credit card. It uses Bluetooth technology to connect to a smartphone and identify six of the most common arrhythmias.

Similarly, recent developments related to companies manufacturing cardiac ambulatory monitoring products have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Cardiac Ambulatory Monitoring Industry Analysis

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2015-2021

Market Analysis

US$ Bn for Value, Volume (Units)

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA).

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Turkey, GCC, South Africa, North Africa and Rest of MEA.

Key Market Segments Covered

Product, end users, and regions

Key Companies Profiled

Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, iRhythm Technologies Inc, Biotronik, Schiller, Medicomp Inc., Koninklijke Philips N.V., Applied Cardiac System, MicroPort

Pricing

Available upon Request

Key Market Segments Covered in the Cardiac Ambulatory Monitoring Industry Research

By Product:

  • ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Cardiac Care Centers
  • Home Care Setting

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global cardiac ambulatory monitoring market is worth US$ 13.3 Bn at end of 2021.

The cardiac ambulatory monitoring market is expected to reach US$ 21.6 Bn by end of 2032 at a CAGR of 4.5%.

Technology advancement in cardiac monitoring devices and increasing sedentary lifestyles among people leading to an increase in the prevalence of cardiovascular diseases are some of the key factors that drive this market.

The North American region has the highest market share of about 36.5% in 2021 in the global cardiac ambulatory monitoring market.

India accounted for about 6.6% of the market share in 2021 in the global cardiac ambulatory monitoring market.

The U.S., China, Germany, Japan and India are the top five countries, which are expected to drive demand in the cardiac ambulatory monitoring market.

Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, iRhythm Technologies Inc, Biotronik, Schiller, Medicomp Inc., Koninklijke Philips N.V., Applied Cardiac System, and MicroPort, are some of the key players in the cardiac ambulatory monitoring industry.

From 2015-2021, the market for cardiac ambulatory monitoring devices expanded at a CAGR of 5.2%.

China accounted for 9.2% of the market share at the end of 2021 in the global market.

Germany displayed a global market share of around 5.6% in 2021 in the cardiac ambulatory monitoring market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology, by Region

    4.2. Key Promotional Strategies by Manufacturers

    4.3. Regulatory Landscape

    4.4. Reimbursement Scenario

    4.5. Value Chain Analysis

    4.6. Product Adoption Analysis

    4.7. PESTEL Analysis

    4.8. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

        5.1.3. Global Cardiac Monitoring Devices Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increasing Complexity of Healthcare Operations

        5.2.2. Product Pricing

        5.2.3. Product Adoption

        5.2.4. Rising Prevalence of Cardiovascular Diseases

        5.2.5. Growing Volumes of Surgical Procedures

        5.2.6. Product Licensing

        5.2.7. Regulatory Scenario

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By End User

        6.1.3. By Region

    6.2. 2021 Market Scenario

7. Global Market Volume (Units) Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Volume (Units) Analysis, 2015-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis, by Products

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2015–2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Bn) Analysis, 2015–2021

    9.2. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2015–2021 and Forecast 2022–2032, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Bn) Analysis, by Product, 2015–2021

    10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2022–2032

        10.3.1. ECG Devices

        10.3.2. Holter Monitors

        10.3.3. Event Monitors

        10.3.4. Implantable Loop Recorders

        10.3.5. Mobile Cardiac Telemetry

    10.4. Market Attractiveness Analysis, by Product

11. Global Market Analysis 2015–2021 and Forecast 2022–2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2015–2021

    11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2022–2032

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

        11.3.3. Specialty Clinics

        11.3.4. Cardiac Care Centers

        11.3.5. Home Care Setting

    11.4. Market Attractiveness Analysis, by End User

12. Global Market Analysis 2015–2021 and Forecast 2022–2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Bn) Analysis, by Region, 2015–2021

    12.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis, by Region

13. North America Market Analysis 2015–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    13.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By End User

    13.5. Market Trends

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Country Level Analysis & Forecast

        13.7.1. U.S. Market Analysis

            13.7.1.1. Introduction

            13.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.1.2.1. By Product

                13.7.1.2.2. By End User

        13.7.2. Canada Market Analysis

            13.7.2.1. Introduction

            13.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.2.2.1. By Product

                13.7.2.2.2. By End User

14. Latin America Market Analysis 2015–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    14.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By End User

    14.5. Market Trends

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. Mexico Market Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By End User

        14.7.2. Brazil Market Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By End User

        14.7.3. Argentina Market Analysis

            14.7.3.1. Introduction

            14.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.3.2.1. By Product

                14.7.3.2.2. By End User

15. Europe Market Analysis 2015–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Bn) and Volume (Unit) Trend Analysis, by Market Taxonomy, 2015–2021

    15.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By End User

    15.5. Market Trends

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Germany Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By End User

        15.7.2. Italy Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By End User

        15.7.3. France Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By End User

        15.7.4. U.K.  Cardiac Ambulatory Monitoring Market Analysis

            15.7.4.1. Introduction

            15.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.4.2.1. By Product

                15.7.4.2.2. By End User

        15.7.5. Spain Market Analysis

            15.7.5.1. Introduction

            15.7.5.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.5.2.1. By Product

                15.7.5.2.2. By End User

        15.7.6. BENELUX Market Analysis

            15.7.6.1. Introduction

            15.7.6.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.6.2.1. By Product

                15.7.6.2.2. By End User

        15.7.7. Russia Market Analysis

            15.7.7.1. Introduction

            15.7.7.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.7.2.1. By Product

                15.7.7.2.2. By End User

16. East Asia Market Analysis 2015–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    16.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By End User

    16.5. Market Trends

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. China Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By End User

        16.7.2. Japan Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By End User

        16.7.3. South Korea Market Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By End User

17. South Asia Market Analysis 2015–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    17.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By End User

    17.5. Market Trends

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. India Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By End User

        17.7.2. Indonesia Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By End User

        17.7.3. Malaysia Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By End User

        17.7.4. Thailand Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.4.2.1. By Product

                17.7.4.2.2. By End User

18. Oceania Market Analysis 2015-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    18.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Australia Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By End User

        18.7.2. New Zealand Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2015–2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2015–2021

    19.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2022–2032

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By End User

    19.5. Market Trends

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. GCC Countries Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.1.2.1. By Product

                19.7.1.2.2. By End User

        19.7.2. Turkey Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.2.2.1. By Product

                19.7.2.2.2. By End User

        19.7.3. South Africa Market Analysis

            19.7.3.1. Introduction

            19.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.3.2.1. By Product

                19.7.3.2.2. By End User

        19.7.4. North Africa Market

            19.7.4.1. Introduction

            19.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.4.2.1. By Product

                19.7.4.2.2. By End User

20. Market Structure Analysis

    20.1. Market Analysis, by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Medtronic Public Health Company

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Key Financials

            21.3.1.6. SWOT Analysis

            21.3.1.7. Strategy Overview

        21.3.2. Abbott Laboratories

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Key Financials

            21.3.2.6. SWOT Analysis

            21.3.2.7. Strategy Overview

        21.3.3. Boston Scientific Corporation

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Key Financials

            21.3.3.6. SWOT Analysis

            21.3.3.7. Strategy Overview

        21.3.4. GE Healthcare

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Key Financials

            21.3.4.6. SWOT Analysis

            21.3.4.7. Strategy Overview

        21.3.5. iRhythm Technologies Inc.

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Key Financials

            21.3.5.6. SWOT Analysis

            21.3.5.7. Strategy Overview

        21.3.6. Biotronik

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Key Financials

            21.3.6.6. SWOT Analysis

            21.3.6.7. Strategy Overview

        21.3.7. Schiller

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Key Financials

            21.3.7.6. SWOT Analysis

            21.3.7.7. Strategy Overview

        21.3.8. Medicomp Inc.

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Key Financials

            21.3.8.6. SWOT Analysis

            21.3.8.7. Strategy Overview

        21.3.9. Koninklijke Philips N.V.

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.9.4. Sales Footprint

            21.3.9.5. Key Financials

            21.3.9.6. SWOT Analysis

            21.3.9.7. Strategy Overview

        21.3.10. Applied Cardiac System

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.10.4. Sales Footprint

            21.3.10.5. Key Financials

            21.3.10.6. SWOT Analysis

            21.3.10.7. Strategy Overview

        21.3.11. MicroPort

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.11.4. Sales Footprint

            21.3.11.5. Key Financials

            21.3.11.6. SWOT Analysis

            21.3.11.7. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 02: Global Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 03: Global Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 04: North America Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 05: North America Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 06: North America Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 07: North America Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 08: Latin America Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 09: Latin America Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 10: Latin America Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 11: Latin America Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 12: Europe Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 13: Europe Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 14: Europe Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 15: Europe Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 16: South Asia Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 17: South Asia Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 18: South Asia Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 19: South Asia Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 20: East Asia Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 21: East Asia Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 22: East Asia Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 23: East Asia Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 24: Oceania Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 25: Oceania Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Table 26: Oceania Market Volume (Units) Analysis and Forecast 2015–2032, by Product

Table 27: Oceania Market Value (US$ Bn) Analysis and Forecast 2015–2032, by End User

Table 28: MEA Market Value (US$ Bn) Analysis 2015-2021 and Forecast 2022–2032, by Country

Table 29: MEA Market Value (US$ Bn) Analysis and Forecast 2015–2032, by Product

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (Units), 2015 – 2021

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Cardiac Ambulatory Monitoring, Pricing Analysis per unit (US$), in 2022

Figure 04: Cardiac Ambulatory Monitoring, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Market Value (US$ Bn) Analysis, 2015–2021

Figure 06: Global Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Market Absolute $ Opportunity (US$ Bn) Analysis, 2022–2032

Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by Product

Figure 10: Global Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by End User

Figure 13: Global Market Attractiveness Analysis 2022–2032, by End User

Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2032, by Region

Figure 16: Global Market Attractiveness Analysis 2022–2032, by Region

Figure 17: North America Market Value (US$ Bn) Analysis, 2015–2021

Figure 18: North America Market Value (US$ Bn) Forecast, 2022-2032

Figure 19: North America Market Value Share, by Product (2022 E)

Figure 20: North America Market Value Share, by End User (2022 E)

Figure 21: North America Market Value Share, by Country (2022 E)

Figure 22: North America Market Attractiveness Analysis by Product, 2022–2032

Figure 23: North America Market Attractiveness Analysis by End User, 2022–2032

Figure 24: North America Market Attractiveness Analysis by Country, 2022–2032

Figure 25: U.S. Market Value Proportion Analysis, 2021

Figure 26: Global Vs. U.S. Growth Comparison

Figure 27: U.S. Market Share Analysis (%) by Product, 2022 & 2032

Figure 28: U.S. Market Share Analysis (%) by End User, 2022 & 2032

Figure 29: Canada Market Value Proportion Analysis, 2021

Figure 30: Global Vs. Canada. Growth Comparison

Figure 31: Canada Market Share Analysis (%) by Product, 2022 & 2032

Figure 32: Canada Market Share Analysis (%) by End User, 2022 & 2032

Figure 33: Latin America Market Value (US$ Bn) Analysis, 2015–2021

Figure 34: Latin America Market Value (US$ Bn) Forecast, 2022-2032

Figure 35: Latin America Market Value Share, by Product (2022 E)

Figure 36: Latin America Market Value Share, by End User (2022 E)

Figure 37: Latin America Market Value Share, by Country (2022 E)

Figure 38: Latin America Market Attractiveness Analysis by Product, 2022–2032

Figure 39: Latin America Market Attractiveness Analysis by End User, 2022–2032

Figure 40: Latin America Market Attractiveness Analysis by Country, 2022–2032

Figure 41: Mexico Market Value Proportion Analysis, 2021

Figure 42: Global Vs Mexico Growth Comparison

Figure 43: Mexico Market Share Analysis (%) by Product, 2022 & 2032

Figure 44: Mexico Market Share Analysis (%) by End User, 2022 & 2032

Figure 45: Brazil Market Value Proportion Analysis, 2021

Figure 46: Global Vs. Brazil. Growth Comparison

Figure 47: Brazil Market Share Analysis (%) by Product, 2022 & 2032

Figure 48: Brazil Market Share Analysis (%) by End User, 2022 & 2032

Figure 49: Argentina Market Value Proportion Analysis, 2021

Figure 50: Global Vs Argentina Growth Comparison

Figure 51: Argentina Market Share Analysis (%) by Product, 2022 & 2032

Figure 52: Argentina Market Share Analysis (%) by End User, 2022 & 2032

Figure 53: Europe Market Value (US$ Bn) Analysis, 2015–2021

Figure 54: Europe Market Value (US$ Bn) Forecast, 2022-2032

Figure 55: Europe Market Value Share, by Product (2022 E)

Figure 56: Europe Market Value Share, by End User (2022 E)

Figure 57: Europe Market Value Share, by Country (2022 E)

Figure 58: Europe Market Attractiveness Analysis by Product, 2022–2032

Figure 59: Europe Market Attractiveness Analysis by End User, 2022–2032

Figure 60: Europe Market Attractiveness Analysis by Country, 2022–2032

Figure 61: UK Market Value Proportion Analysis, 2021

Figure 62: Global Vs. UK Growth Comparison

Figure 63: UK Market Share Analysis (%) by Product, 2022 & 2032

Figure 64: UK Market Share Analysis (%) by End User, 2022 & 2032

Figure 65: Germany Market Value Proportion Analysis, 2021

Figure 66: Global Vs. Germany Growth Comparison

Figure 67: Germany Market Share Analysis (%) by Product, 2022 & 2032

Figure 68: Germany Market Share Analysis (%) by End User, 2022 & 2032

Figure 69: Italy Market Value Proportion Analysis, 2021

Figure 70: Global Vs. Italy Growth Comparison

Figure 71: Italy Market Share Analysis (%) by Product, 2022 & 2032

Figure 72: Italy Market Share Analysis (%) by End User, 2022 & 2032

Figure 73: France Market Value Proportion Analysis, 2021

Figure 74: Global Vs France Growth Comparison

Figure 75: France Market Share Analysis (%) by Product, 2022 & 2032

Figure 76: France Market Share Analysis (%) by End User, 2022 & 2032

Figure 77: Spain Market Value Proportion Analysis, 2021

Figure 78: Global Vs Spain Growth Comparison

Figure 79: Spain Market Share Analysis (%) by Product, 2022 & 2032

Figure 80: Spain Market Share Analysis (%) by End User, 2022 & 2032

Figure 81: Russia Market Value Proportion Analysis, 2021

Figure 82: Global Vs Russia Growth Comparison

Figure 83: Russia Market Share Analysis (%) by Product, 2022 & 2032

Figure 84: Russia Market Share Analysis (%) by End User, 2022 & 2032

Figure 85: BENELUX Market Value Proportion Analysis, 2021

Figure 86: Global Vs BENELUX Growth Comparison

Figure 87: BENELUX Market Share Analysis (%) by Product, 2022 & 2032

Figure 88: BENELUX Market Share Analysis (%) by End User, 2022 & 2032

Figure 89: East Asia Market Value (US$ Bn) Analysis, 2015–2021

Figure 90: East Asia Market Value (US$ Bn) Forecast, 2022-2032

Figure 91: East Asia Market Value Share, by Product (2022 E)

Figure 92: East Asia Market Value Share, by End User (2022 E)

Figure 93: East Asia Market Value Share, by Country (2022 E)

Figure 94: East Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 95: East Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 96: East Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 97: China Market Value Proportion Analysis, 2021

Figure 98: Global Vs. China Growth Comparison

Figure 99: China Market Share Analysis (%) by Product, 2022 & 2032

Figure 100: China Market Share Analysis (%) by End User, 2022 & 2032

Figure 101: Japan Market Value Proportion Analysis, 2021

Figure 102: Global Vs. Japan Growth Comparison

Figure 103: Japan Market Share Analysis (%) by Product, 2022 & 2032

Figure 104: Japan Market Share Analysis (%) by End User, 2022 & 2032

Figure 105: South Korea Market Value Proportion Analysis, 2021

Figure 106: Global Vs South Korea Growth Comparison

Figure 107: South Korea Market Share Analysis (%) by Product, 2022 & 2032

Figure 108: South Korea Market Share Analysis (%) by End User, 2022 & 2032

Figure 109: South Asia Market Value (US$ Bn) Analysis, 2015–2021

Figure 110: South Asia Market Value (US$ Bn) Forecast, 2022-2032

Figure 111: South Asia Market Value Share, by Product (2022 E)

Figure 112: South Asia Market Value Share, by End User (2022 E)

Figure 113: South Asia Market Value Share, by Country (2022 E)

Figure 114: South Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 115: South Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 116: South Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 117: India Market Value Proportion Analysis, 2021

Figure 118: Global Vs. India Growth Comparison

Figure 119: India Market Share Analysis (%) by Product, 2022 & 2032

Figure 120: India Market Share Analysis (%) by End User, 2022 & 2032

Figure 121: Indonesia Market Value Proportion Analysis, 2021

Figure 122: Global Vs. Indonesia Growth Comparison

Figure 123: Indonesia Market Share Analysis (%) by Product, 2022 & 2032

Figure 124: Indonesia Market Share Analysis (%) by End User, 2022 & 2032

Figure 125: Malaysia Market Value Proportion Analysis, 2021

Figure 126: Global Vs. Malaysia Growth Comparison

Figure 127: Malaysia Market Share Analysis (%) by Product, 2022 & 2032

Figure 128: Malaysia Market Share Analysis (%) by End User, 2022 & 2032

Figure 129: Thailand Market Value Proportion Analysis, 2021

Figure 130: Global Vs. Thailand Growth Comparison

Figure 131: Thailand Market Share Analysis (%) by Product, 2022 & 2032

Figure 132: Thailand Market Share Analysis (%) by End User, 2022 & 2032

Figure 133: Oceania Market Value (US$ Bn) Analysis, 2015–2021

Figure 134: Oceania Market Value (US$ Bn) Forecast, 2022-2032

Figure 135: Oceania Market Value Share, by Product (2022 E)

Figure 136: Oceania Market Value Share, by End User (2022 E)

Figure 137: Oceania Market Value Share, by Country (2022 E)

Figure 138: Oceania Market Attractiveness Analysis by Product, 2022–2032

Figure 139: Oceania Market Attractiveness Analysis by End User, 2022–2032

Figure 140: Oceania Market Attractiveness Analysis by Country, 2022–2032

Figure 141: Australia Market Value Proportion Analysis, 2021

Figure 142: Global Vs. Australia Growth Comparison

Figure 143: Australia Market Share Analysis (%) by Product, 2022 & 2032

Figure 144: Australia Market Share Analysis (%) by End User, 2022 & 2032

Figure 145: New Zealand Market Value Proportion Analysis, 2021

Figure 146: Global Vs New Zealand Growth Comparison

Figure 147: New Zealand Market Share Analysis (%) by Product, 2022 & 2032

Figure 148: New Zealand Market Share Analysis (%) by End User, 2022 & 2032

Figure 149: Middle East & Africa Market Value (US$ Bn) Analysis, 2015–2021

Figure 150: Middle East & Africa Market Value (US$ Bn) Forecast, 2022-2032

Figure 151: Middle East & Africa Market Value Share, by Product (2022 E)

Figure 152: Middle East & Africa Market Value Share, by End User (2022 E)

Figure 153: Middle East & Africa Market Value Share, by Country (2022 E)

Figure 154: Middle East & Africa Market Attractiveness Analysis by Product, 2022–2032

Figure 155: Middle East & Africa Market Attractiveness Analysis by End User, 2022–2032

Figure 156: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032

Figure 157: GCC Countries Market Value Proportion Analysis, 2021

Figure 158: Global Vs GCC Countries Growth Comparison

Figure 159: GCC Countries Market Share Analysis (%) by Product, 2022 & 2032

Figure 160: GCC Countries Market Share Analysis (%) by End User, 2022 & 2032

Figure 161: Turkey Market Value Proportion Analysis, 2021

Figure 162: Global Vs. Turkey Growth Comparison

Figure 163: Turkey Market Share Analysis (%) by Product, 2022 & 2032

Figure 164: Turkey Market Share Analysis (%) by End User, 2022 & 2032

Figure 165: South Africa Market Value Proportion Analysis, 2021

Figure 166: Global Vs. South Africa Growth Comparison

Figure 167: South Africa Market Share Analysis (%) by Product, 2022 & 2032

Figure 168: South Africa Market Share Analysis (%) by End User, 2022 & 2032

Figure 169: North Africa Market Value Proportion Analysis, 2021

Figure 170: Global Vs North Africa Growth Comparison

Figure 171: North Africa Market Share Analysis (%) by Product, 2022 & 2032

Figure 172: North Africa Market Share Analysis (%) by End User, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cardiac Rhythm Remote Monitoring Devices Market

Published : October 2017

Healthcare

Cardiac Surgery Devices Market

Published : August 2017

Healthcare

Cardiac Assist Devices Market

Published : August 2021

Google translate

Cardiac Ambulatory Monitoring Market